ASPI — ASP Isotopes Inc.
US-listed developer of laser-based uranium enrichment technology; targeting HALEU production; pre-commercial.
Coiled
0
52w range compression, breakout-adjusted
Watched
4
7-day news volume + tape quietness
Sound
50
Margins, growth, FCF composite
Critical
100
Supply-chain concentration × demand
Pressure
41
Pricing Power
17.6%
Inflating
CHAIN-D scores pending — refresh after next quarterly run.
Numbers on the wire.
Market cap
$891M
P/E (TTM)
—
P/S (TTM)
33.10
EV / EBITDA
—
Gross margin
17.62%
Op margin
-285.37%
Net margin
-644.40%
FCF margin
—
Rev growth YoY
511.17%
EPS growth YoY
—
ROE
-117.16%
ROA
-47.95%
Debt / Equity
0.90
Current ratio
4.39
Price / Book
1.91
Beta
3.58
Layer Presence.
Pre-commercial enrichment technology play; if laser enrichment scales, ASPI could disrupt conventional centrifuge economics; speculative but relevant to HALEU supply chain.